How can we improve the diagnostic value of donor kidney graft biopsies and the management of renal transplant recipients? A recent study developed a morphologic scoring system—the Maryland Aggregate Pathology Index—to help predict long-term renal graft survival from preimplantation donor organ biopsy findings.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Histopathological findings in transplanted kidneys
Renal Replacement Therapy Open Access 16 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Munivenkatappa, R. B. et al. The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am. J. Transplant. 8, 2316–2324 (2008).
Solez, K. et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am. J. Transplant. 8, 753–760 (2008).
Racusen, L. C. et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55, 713–723 (1999).
Solez, K. et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 44, 411–422 (1993).
Remuzzi, G. et al. Long-term outcome of renal transplantation from older donors. N. Engl. J. Med. 354, 343–352 (2006).
Fritsche, L. et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am. J. Transplant. 3, 1434–1439 (2003).
Segoloni, G. P. et al. Preferential allocation of marginal kidney allografts to elderly recipients combined with modified immunosuppression gives good results. Transplantation 80, 953–958 (2005).
Smits, J. M., Persijn, G. G., van Houwelingen, H. C., Claas, F. H. & Frei, U. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am. J. Transplant. 2, 664–670 (2002).
Savoye, E., Tamarelle, D., Chalem, Y., Rebibou, J. M. & Tuppin, P. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60 years and over. Transplantation 84, 1618–1624 (2007).
Frei, U. et al. Prospective age-matching in elderly kidney transplant recipients—a 5-year analysis of the Eurotransplant Senior Program. Am. J. Transplant. 8, 50–57 (2008).
Haas, M., Ratner, L. E. & Montgomery, R. A. C4d staining of perioperative renal transplant biopsies. Transplantation 74, 711–717 (2002).
Nickeleit, V. Pathology of renal transplantation. in Transplantation Pathology (ed. Ruiz, P.) 45–110 (Cambridge University Press, 2009).
Pascual, J., Marcén, R. & Ortuño, J. Clinical experience with everolimus (Certican) in elderly recipients: the “old-for-old” concept. Transplantation 79, S85–S88 (2005).
Gill, J. et al. Outcomes of kidney transplantation from older living donors to older recipients. Am. J. Kidney Dis. 52, 541–552 (2008).
Arns, W., Citterio, F. & Campistol, J. M. 'Old-for-old'—new strategies for renal transplantation. Nephrol. Dial. Transplant. 22, 336–341 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Nickeleit, V. Donor biopsy evaluation at time of renal grafting. Nat Rev Nephrol 5, 249–251 (2009). https://doi.org/10.1038/nrneph.2009.50
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2009.50
This article is cited by
-
Histopathological findings in transplanted kidneys
Renal Replacement Therapy (2017)
-
Clinical role of the renal transplant biopsy
Nature Reviews Nephrology (2012)
-
Assessment of kidney organ quality and prediction of outcome at time of transplantation
Seminars in Immunopathology (2011)